9 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Neurobehavioral Manifestations, Neurologic Manifestations, Sex Chromosome Disorders, X-linked disease, chromosomal disorder, fragile X syndrome, hereditary disease, inherited neurodegenerative disorder, intellectual disability, nervous system disorderRecruitingPhase 22026-09-29NCT07209462
Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorderanxiety disorder, generalized anxiety disorder, psychiatric disorderRecruitingPhase 22026-09-25NCT06701903
Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorderanxiety disorder, generalized anxiety disorder, psychiatric disorderRecruitingPhase 22026-09-25NCT06480383
A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in AdultsEpisodic MigraineActive, not recruitingPhase 32026-09-04NCT06047457
A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in AdultsChronic MigraineActive, not recruitingPhase 32026-09-04NCT06047444
Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRDDepressive Disorder, Treatment-Resistant, depressive disorder, mood disorder, psychiatric disorderActive, not recruitingPhase 32026-08-10NCT05711940
ML-004 Open-Label Extension Study in Adults and Adolescents With Autism Spectrum Disorders (ASD)autism, autism spectrum disorder, neurodevelopmental disorder, pervasive developmental disorder, psychiatric disorderActive, not recruitingPhase 22026-07-20NCT05889273
A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early ADAlzheimer disease, Cognition Disorders, Cognitive Dysfunction, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathyActive, not recruitingPhase 32026-05-18NCT06709014
An Open-Label Extension Study of BPN14770 in Subjects With Fragile X SyndromeCongenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Neurobehavioral Manifestations, Neurologic Manifestations, Sex Chromosome Disorders, X-linked disease, chromosomal disorder, fragile X syndrome, hereditary disease, inherited neurodegenerative disorder, intellectual disability, nervous system disorderActive, not recruitingPhase 32025-10-03NCT05367960